Latest filing: ESOP/ESOS/ESPS - Sai Life Sciences Limited
ObservedCompany dossier
Sai Life Sciences
NSE:SAILIFE · ISIN INE570L01029
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Sai Life Sciences
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹439.8 Cr · PAT ₹53.9 Cr.
Exchange XBRLLatest ownership: promoter group 34.53% and public 65.47% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Sai Life Sciences Limited: [ICRA]AA(Stable)/[ICRA]A1+ assigned
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing ESOP/ESOS/ESPS - Sai Life Sciences Limited
NSE · exchange filing
Observed
Source filing Sai Life Sciences Ltd - 544306 - Announcement under Regulation 30 (LODR)-Allotment
BSE · exchange filing
Observed
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Sai Life Sciences Limited
NSE · exchange filing
Observed
Source filing Sai Life Sciences Ltd - 544306 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹439.8 Cr
- Profit after tax
- ₹53.9 Cr
- EPS
- ₹2.89
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 34.53%
- Public
- 65.47%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL